Asian Pacific Society of Cardiology Consensus Statement on Management of Coronary Artery Disease in Adults with Late Complications of Kawasaki Disease

Despite reductions in the mortality of Kawasaki disease with advances in its treatment, a proportion of patients still develop coronary artery dilatation that may persist even into adulthood. These lesions carry an increased risk of myocardial ischaemia and infarction. However, published clinical guidelines on the management and long-term follow up of patients with these late complications of Kawasaki disease are limited. The Asian Pacific Society of Cardiology convened an expert panel to review the available literature and develop consensus recommendations to guide clinicians in this area. The panel developed statements on the assessment and risk stratification of coronary artery disease, investigations for follow up, as well as considerations around treatment of stenotic lesions with medical therapy, percutaneous coronary intervention and coronary artery bypass grafting. Each statement was voted on by each panel member and consensus was reached when 80% of experts voted ‘agree’ or ‘neutral’. This process resulted in the development of consensus recommendations to guide cardiologists and internists in the follow up and management of patients with coronary artery lesions as a late complication of Kawasaki disease.

[1]  Deepak L. Bhatt,et al.  2020 ACC Expert Consensus Decision Pathway for Anticoagulant and Antiplatelet Therapy in Patients With Atrial Fibrillation or Venous Thromboembolism Undergoing Percutaneous Coronary Intervention or With Atherosclerotic Cardiovascular Disease: A Report of the American College of Cardiology Solution S , 2020, Journal of the American College of Cardiology.

[2]  H. Gray,et al.  Lifetime cardiovascular management of patients with previous Kawasaki disease , 2019, Heart.

[3]  T. Maddox,et al.  2019 Methodology for Creating Expert Consensus Decision Pathways: A Report of the American College of Cardiology. , 2019, Journal of the American College of Cardiology.

[4]  K. Waki,et al.  Emergence and Characterization of Acute Coronary Syndrome in Adults After Confirmed or Missed History of Kawasaki Disease in Japan: A Japanese Nationwide Survey , 2019, Front. Pediatr..

[5]  C. Rihal,et al.  Management of Coronary Artery Aneurysms. , 2018, JACC. Cardiovascular interventions.

[6]  E. Tsuda,et al.  Cardiac Events and the Maximum Diameter of Coronary Artery Aneurysms in Kawasaki Disease , 2017, The Journal of pediatrics.

[7]  J. Newburger,et al.  Coronary Artery Aneurysms in Kawasaki Disease: Risk Factors for Progressive Disease and Adverse Cardiac Events in the US Population , 2016, Journal of the American Heart Association.

[8]  Y. Arakaki,et al.  A New Z Score Curve of the Coronary Arterial Internal Diameter Using the Lambda-Mu-Sigma Method in a Pediatric Population. , 2016, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[9]  E. Tsuda Intervention in Adults After Kawasaki Disease. , 2016, JACC: Cardiovascular Interventions.

[10]  J. Burns,et al.  The Spectrum of Cardiovascular Lesions Requiring Intervention in Adults After Kawasaki Disease. , 2016, JACC. Cardiovascular interventions.

[11]  T. Ueno,et al.  Statin reduces persistent coronary arterial inflammation evaluated by serial ¹⁸fluorodeoxyglucose positron emission tomography imaging long after Kawasaki disease. , 2015, International journal of cardiology.

[12]  D. Wortham,et al.  Giant coronary artery aneurysms: review and update. , 2014, Texas Heart Institute journal.

[13]  K. Hamaoka,et al.  A survey of the 3-decade outcome for patients with giant aneurysms caused by Kawasaki disease. , 2014, American heart journal.

[14]  Toshiaki Shimizu,et al.  National Japanese survey of thrombolytic therapy selection for coronary aneurysm: Intracoronary thrombolysis or intravenous coronary thrombolysis in patients with Kawasaki disease , 2013, Pediatrics international : official journal of the Japan Pediatric Society.

[15]  H. Sugiyama,et al.  The 30-Year Outcome for Patients After Myocardial Infarction Due to Coronary Artery Lesions Caused By Kawasaki Disease , 2011, Pediatric Cardiology.

[16]  Y. Arakaki,et al.  Standard method for ultrasound imaging of coronary artery in children , 2010, Pediatrics international : official journal of the Japan Pediatric Society.

[17]  M. Ishii,et al.  Percutaneous coronary intervention versus coronary artery bypass grafting for stenotic lesions after Kawasaki disease. , 2010, The Journal of pediatrics.

[18]  B. McCrindle,et al.  Long-Term Anticoagulation in Kawasaki Disease: Initial Use of Low Molecular Weight Heparin is a Viable Option for Patients with Severe Coronary Artery Abnormalities , 2010, Pediatric Cardiology.

[19]  S. Kitamura,et al.  Twenty-Five-Year Outcome of Pediatric Coronary Artery Bypass Surgery for Kawasaki Disease , 2009, Circulation.

[20]  T. Matsuishi,et al.  Multicenter and retrospective case study of warfarin and aspirin combination therapy in patients with giant coronary aneurysms caused by Kawasaki disease. , 2009, Circulation journal : official journal of the Japanese Circulation Society.

[21]  H. Shimpo,et al.  In Vivo Plaque Composition and Morphology in Coronary Artery Lesions in Adolescents and Young Adults Long After Kawasaki Disease: A Virtual Histology–Intravascular Ultrasound Study , 2009, Circulation.

[22]  T. Matsuishi,et al.  Warfarin Therapy for Giant Aneurysm Prevents Myocardial Infarction in Kawasaki Disease , 2008, Pediatric Cardiology.

[23]  M. Takamuro,et al.  Percutaneous Transluminal Coronary Rotational Atherectomy for Localized Stenosis Caused by Kawasaki Disease , 2006, Pediatric Cardiology.

[24]  D. Cokkinos,et al.  Coronary artery ectasias: imaging, functional assessment and clinical implications. , 2006, European heart journal.

[25]  T. Akagi Interventions in Kawasaki Disease , 2005, Pediatric Cardiology.

[26]  T. Kimball,et al.  Dobutamine Stress Echocardiography in the Evaluation of Young Patients with Kawasaki Disease , 2003, Pediatric Cardiology.

[27]  J. Furui,et al.  Sequential Follow-Up Results of Catheter Intervention for Coronary Artery Lesions After Kawasaki Disease: Quantitative Coronary Artery Angiography and Intravascular Ultrasound Imaging Study , 2002, Circulation.

[28]  Toshiko Yamaguchi,et al.  Guidelines for catheter intervention in coronary artery lesion in Kawasaki disease , 2001, Pediatrics international : official journal of the Japan Pediatric Society.

[29]  D. Cokkinos,et al.  The natural history of aneurysmal coronary artery disease. , 1997, Heart.

[30]  J. Takaya,et al.  Application of percutaneous transluminal coronary angioplasty to coronary arterial stenosis in Kawasaki disease. , 1996, Circulation.

[31]  T. Okada,et al.  Dobutamine stress echocardiography for detection of coronary artery stenosis in children with Kawasaki disease. , 1996, Journal of the American College of Cardiology.

[32]  I. Hashimoto,et al.  Successful thrombolytic therapy using tissue-type plasminogen activator in Kawasaki disease , 1995, Pediatric Cardiology.

[33]  Y. Arakaki,et al.  Fate of coronary arterial aneurysms in Kawasaki disease. , 1994, The American journal of cardiology.

[34]  L. Fisher,et al.  Aneurysmal Coronary Artery Disease , 1983, Circulation.

[35]  Y. Hamashima,et al.  Pathology of the heart in Kawasaki disease. , 1978, Pediatrics.

[36]  B. McCrindle,et al.  Coronary Artery Bypass Grafting and Percutaneous Coronary Intervention after Kawasaki Disease: The Pediatric Canadian Series , 2016, Pediatric Cardiology.

[37]  JCSJointWorkingGroup Guidelines for drug therapy in pediatric patients with cardiovascular diseases (JCS 2012). Digest version. , 2014, Circulation journal : official journal of the Japanese Circulation Society.

[38]  Guidelines for Diagnosis and Management of Cardiovascular Sequelae in Kawasaki Disease ( JCS 2013 ) – Digest Version – JCS Joint Working Group Table of Contents , 2014 .

[39]  S. Shulman,et al.  Feasibility of exercise stress echocardiography for the follow-up of children with coronary involvement secondary to Kawasaki disease. , 1995, Circulation.